# Clinical Study Phase III, Randomized, Double-blind, Prospective and Comparative to Evaluate the Efficacy and Tolerability of Using APETIVITON BC Compared to Petivit BC in Appetite Stimulate.

> **NCT01086865** · PHASE3 · UNKNOWN · sponsor: **Cifarma Cientifica Farmaceutica Ltda** · enrollment: 150 (estimated)

## Conditions studied

- Inappetence

## Interventions

- **DRUG:** Apetiviton BC

## Key facts

- **NCT ID:** NCT01086865
- **Lead sponsor:** Cifarma Cientifica Farmaceutica Ltda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-08
- **Primary completion:** 2010-11
- **Final completion:** 2011-01
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2010-05-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01086865

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01086865, "Clinical Study Phase III, Randomized, Double-blind, Prospective and Comparative to Evaluate the Efficacy and Tolerability of Using APETIVITON BC Compared to Petivit BC in Appetite Stimulate.". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01086865. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*